Downstream effectors of Akt, like mTORC1, MEK-ERK, and Src-ERK, have been associated with cholangiocarcinoma cells [87], induction of stemness markers [88], and amoeboid motility [89]. Here, MAP2K7 is linked to cholangiocarcinoma.